Government contracts aim at building flu vaccine supplies

July 2009
Fire Engineering;Jul2009, Vol. 162 Issue 7, p34
Trade Publication
The article reports on the move of the U.S. Department of Health and Human Services (HHS) to secure contracts aimed at providing adequate supply of influenza A (H1N1) vaccine. The HHS gave companies licensed to produce influenza vaccines additional orders to manufacture vaccine antigens and adjuvants. The findings of a study by R. J. Garten et al about the genetic aspects of the A (H1N1) virus are detailed. A total of 6,765 influenza A (H1N1) cases occurred in the U.S. as of May 25, 2009, according to the Centers for Disease Control and Prevention (CDC).


Related Articles

  • HHS Directing $1B for H1N1 Swine Flu Vaccine. Young, Donna // BioWorld Today;5/26/2009, Vol. 20 Issue 99, p1 

    This article reports on the allocation of funds by the U.S. Department of Health and Human Services (HHS) for clinical studies and commercial-scale production of vaccine antigen and adjuvants against the 2009 H1N1 swine-origin influenza A virus. HHS Secretary Kathleen Sebelius said she is...

  • H1N1 Vaccinations Likely to Start in Mid-October.  // BioWorld Today;7/13/2009, Vol. 20 Issue 132, p5 

    This article reports on the plan of the U.S. Department of Health and Human Services (HHS) to launch a mass vaccination program to protect against the H1N1 swine-origin influenza A virus in October 2009. According to HHS Secretary Kathleen Sebelius, the supply of vaccines under the program will...

  • Aggressive Steps Are Being Pursued To Accelerate The Production Of Seasonal Flu Vaccines.  // AirGuide Online.com;5/25/2009, p1 

    The article offers information on the efforts being made in the U.S. to increase the production of seasonal flu vaccines. According to U.S. Health and Human Services secretary Kathleen Sebelius, U.S. has not yet placed orders for the H1N1 flu vaccines which are being researched by several companies.

  • GAS PRESIDENT'S COMMENTS AND REPORT FROM THE ACADEMY COUNCIL. McDonough, Bob // Georgia Journal of Science;2009, Vol. 67 Issue 2, p2 

    The article presents the insights of the Georgia Academy of Science's president on economic and health issues in the U.S. He mentions that the annual meeting at Spelman College was a successful one. He remarks that the U.S. Department of Health and Human Services Secretary will spend 1 billion...

  • US Slashes Swine Flu Vaccine Estimate.  // Clinical Infectious Diseases;10/15/2009, Vol. 49 Issue 8, pi 

    The article reports on the decision of U.S. officials to cut their estimate for the availability of swine influenza vaccine. The Department of Health and Human Services announced that about 45 million doses of the new H1N1 vaccine would be available in the mid-October 2009. It indicates that the...

  • Novavax, VaxInnate Get Welcome Shot in the Arm. Serebrov, Mari // BioWorld Today;3/2/2011, Vol. 22 Issue 41, p1 

    The article reports on the contracts awarded by the U.S. Department of Health and Human Services (HHS) to Novavax Inc. and VaxInnate Inc. Under the contract, Novavax will receive 97 million U.S. dollars over the first three years to bring its seasonal influenza recombinant virus-like particle...

  • Swine flu agitates the adjuvant debate. Schubert, Charlotte // Nature Medicine;Sep2009, Vol. 15 Issue 9, p986 

    The article reports on the move of the U.S. regulatory agencies to decide on whether to approve the use of adjuvants for pandemic H1N1 flu vaccine on an emergency basis. According to Ripley Ballou, deputy director for vaccines at the Bill and Melinda Gates Foundation, if the agencies decide not...

  • Three Things.  // Pharmaceutical Representative;Jul2009, Vol. 39 Issue 7, p9 

    The article offers news briefs related to the U.S. pharmaceutical industry. It reports that the Department of Health and Human Services (HHS) laid $190 million with Sanofi Pasteur to purchase a vaccine for influenza A (H1N1) infection. It notes that a judge will allow the use of CafePharma's...

  • Boosting our best shot. Schubert, Charlotte // Nature Medicine;Sep2009, Vol. 15 Issue 9, p984 

    The article focuses on various discoveries which could translate into a wider range of adjuvants helpful in the provision of future protection against diseases that range from malaria to H1N1 flu. It notes the achievement of researcher Max Theiler hitting a version of the yellow fever virus...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics